vs
Side-by-side financial comparison of Plymouth Industrial REIT, Inc. (PLYM) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $51.2M, roughly 1.3× Plymouth Industrial REIT, Inc.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -106.3%, a 145.7% gap on every dollar of revenue.
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
PLYM vs SLNO — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $51.2M | $66.0M |
| Net Profit | $-54.4M | $26.0M |
| Gross Margin | — | 98.3% |
| Operating Margin | -102.5% | 33.5% |
| Net Margin | -106.3% | 39.4% |
| Revenue YoY | -1.4% | — |
| Net Profit YoY | -248.5% | 134.0% |
| EPS (diluted) | $-1.23 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $51.2M | $66.0M | ||
| Q2 25 | $47.2M | $32.7M | ||
| Q1 25 | $45.6M | — | ||
| Q4 24 | $47.6M | — | ||
| Q3 24 | $51.9M | — | ||
| Q2 24 | $48.7M | — | ||
| Q1 24 | $50.2M | — | ||
| Q4 23 | $50.8M | — |
| Q3 25 | $-54.4M | $26.0M | ||
| Q2 25 | $-6.1M | $-4.7M | ||
| Q1 25 | $5.8M | — | ||
| Q4 24 | $147.4M | — | ||
| Q3 24 | $-15.6M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $6.2M | — | ||
| Q4 23 | $9.3M | — |
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | -102.5% | 33.5% | ||
| Q2 25 | -10.3% | -20.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -29.6% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | -106.3% | 39.4% | ||
| Q2 25 | -12.9% | -14.4% | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 309.9% | — | ||
| Q3 24 | -30.1% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 12.4% | — | ||
| Q4 23 | 18.3% | — |
| Q3 25 | $-1.23 | $0.47 | ||
| Q2 25 | $-0.14 | $-0.09 | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $3.24 | — | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | $0.14 | — | ||
| Q4 23 | $0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $470.1M | $494.8M |
| Total Assets | $1.6B | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $646.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $873.4M | — |
| Q3 25 | $470.1M | $494.8M | ||
| Q2 25 | $539.6M | $240.1M | ||
| Q1 25 | $571.0M | — | ||
| Q4 24 | $579.5M | — | ||
| Q3 24 | $436.5M | — | ||
| Q2 24 | $475.2M | — | ||
| Q1 24 | $484.6M | — | ||
| Q4 23 | $483.0M | — |
| Q3 25 | $1.6B | $599.9M | ||
| Q2 25 | $1.6B | $332.3M | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — | ||
| Q4 23 | $1.4B | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.12× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 1.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $43.5M |
| Free Cash FlowOCF − Capex | — | $43.5M |
| FCF MarginFCF / Revenue | — | 65.8% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $20.0M | $43.5M | ||
| Q2 25 | $23.4M | $-12.6M | ||
| Q1 25 | $15.6M | — | ||
| Q4 24 | $96.1M | — | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $19.9M | — | ||
| Q1 24 | $16.6M | — | ||
| Q4 23 | $18.6M | — |
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | 1.67× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.67× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.12× | — | ||
| Q1 24 | 2.67× | — | ||
| Q4 23 | 2.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
